Does 23andMe’s decline show genetic-based medicine has been overhyped?

23andMe’s DNA test was once named “invention of the year”, but now the company is in dire financial straits. Is this a sign that genetically based medicine’s promise has been exaggerated?

​23andMe’s DNA test was once named “invention of the year”, but now the company is in dire financial straits. Is this a sign that genetically based medicine’s promise has been exaggerated? 23andMe’s DNA test was once named “invention of the year”, but now the company is in dire financial straits. Is this a sign that genetically based medicine’s promise has been exaggerated? 

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top